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Abstract
Background Despite excellent results of bariatric surgery in
the treatment of type 2 diabetes and weight loss in human
subjects, some patients do not obtain desired results. One of
the reasons for this is that not all patients follow caloric intake
recommendations.
Aim The aim of this study was to investigate the effect of
duodenojejunal omega switch (DJOS) surgery on body
weight, glucose tolerance, and incretins in rats.
Methods DJOS and SHAM surgery were performed on rats
maintained for 8 weeks on high-fat diet (HF) and control diet
(CD), respectively. After surgery, four groups were kept on the
same diet as before the surgery, and four groups had a changed
diet (CD vs. HF and HF vs. CD) for the next 8 weeks. Glucose
tolerance, insulin tolerance, glucose-stimulated insulin,
glucagon-like peptide-1 (GLP-1) and gastric inhibitory
polypeptide/glucose-dependent insulinotropic polypeptide
(GIP) secretion, food intake, and body weight were measured.
Results A change of diet after surgery resulted in reduced
glucose tolerance. Plasma insulin levels were lowered be-
tween DJOS and SHAM surgeries for the HF/HF and CD/
HF groups. DJOS surgery did not reduce body weight in the
studied groups, irrespective of diet. In the HF/HF group,
ΔGLP-1 was lower for DJOS surgery in comparison with
other groups. Differences of weight changes were observed
for groups HF/HF and HF/CD. After DJOS surgery, ΔGIP
was lower in the CD/HF group compared with HF/HF.
Conclusions Our results show that applications of different
types of diets, before and after surgery, is a sensitive method
for studies of mechanism of glucose intolerance after DJOS
surgery.
Keywords Bariatric surgery . DJOS surgery . Obesity .
Experimental rat model . Incretins . OGTT . Glucose
tolerance . Insulin intolerance . GIP . GLP-1
Introduction
One of the most effective treatments for long-term weight loss
and energy control is bariatric surgery, where still new surgical
techniques are being developed [1, 2]. Despite excellent re-
sults in the treatment of type 2 diabetes, and long-term weight
loss in human subjects after bariatric surgery [3, 4], some
patients that have undergone surgery do not achieve the ex-
pected positive results. It so happened that one of the reasons
for this failure is that not all patients that undergo surgery
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follow caloric and macronutrient intake recommendations fol-
lowing the operation [5, 6]. Other studies show that significant
reduction in dietary fat preference and intake contributed to
reduced weight loss maintenance in rats and humans follow-
ing the operation [7]. According to Chikunguwo et al. [8],
40% of patients who underwent metabolic surgery showed a
recurrence of T2DM and an increase in body weight. The
reduction of T2DM and decreased obesity are connected with
stable weight loss, age, gender, sex, and BMI before and after
surgery [9–12]. In experimental animal models, such as the
one involving Sprague-Dawley rats, diet-induced obesity and
increases in insulin and lipid levels were observed but not
always with an associated increase in blood glucose levels
[8, 13, 14]. In the spontaneously diabetic rat model, Zucker
diabetic fatty (ZDF), a high-fat diet (HF) accelerated the onset
and severity of hyperglycemia [15]. It has also been reported
that variations of metabolic response to diet-induced obesity
for different animal strains are likely to be related to their
genetic backgrounds. [16]. Glucagon-like peptide-1 (GLP-1)
and gastric inhibitory polypeptide/glucose-dependent
insulinotropic polypeptide (GIP) are incretins and peptide hor-
mones that are released from the gastrointestinal tract into the
circulatory system in response to nutrient ingestion that ame-
liorate glucose-stimulated insulin secretion. GLP-1 is known
to stimulate insulin release from pancreatic β-cells and inhibit
secretion of glucagon from α-cells. GLP-1 further improves
peripheral insulin sensitivity and promotes β-cell prolifera-
tion. GIP is secreted from K cell granules concentrated in
the upper small intestine, and GLP-1 is secreted from L cell
granules, located in the lower small intestine and colon
[17–19]. It is known that a diet rich in nutrients, as well as
bariatric surgery, are both strong stimulants of GLP-1 and GIP
secretion [18–20].
With these data in mind, our aim was to study the effect of
duodenojejunal omega switch (DJOS) surgery on glucose ad-
ministration parameters. In our experimental design, we sim-
ulated the observations that not all patients reduce dietary fat
intake after surgery by maintaining some animals on a HF
after surgery. We also included the possibility that after sur-
gery patients may switch from a regular diet to a HF and from
a HF to a regular diet. Then we assessed the effect of
duodenojejunal omega switch surgery in combination with
CD, and a HF diet, before and after surgery, on body weight,
glucose tolerance, and insulin resistance.
Materials and Methods
Animals and Diets
Male Sprague-Dawley rats (Charles River Breeding
Laboratories, Wilmington, MA) aged 7 weeks, 200 ± 7 g,
were housed at a 12-h light–dark cycle, 22 °C, and 40–60%
humidity. All rats had free access to water and rat food
(ProvimiKliba AG, Kaiseraugst, Switzerland). The control
group was maintained on ssniff® EF R/M. Obesity was in-
duced by placing the animals on a HF (23.0 kJ/g, 59% fat,
27% carbohydrate, and 14% (EF RAT [E15744] Ssniff
Spezialdiäten GmbH) for an average of 2 months. Animals
maintained on the HF diet were pair-fed (kcals) with the ani-
mals exposed to an ad libitum control diet. The energy content
of the high-fat and standard diets were 5.04 and 3.59 kcal/g
(20.1 and 15.0 kJ/g), respectively. Since there were multiple
rats in each cage, the calorie intake was calculated by dividing
the total cage calorie intake by the number of animals per
cage. Rats were fasted overnight before surgery and given oral
glucose tolerance tests (OGTTs).
Experimental Design
After 1 week of acclimatization, the rats were assigned to the
CD (n = 28) and HF groups (n = 28). After 8 weeks, both
groups underwent SHAM (n = 14) and DJOS (n = 14) surger-
ies (Fig. 1b, c). After the surgery, animals from the CD and HF
groups were divided further into eight groups: seven animals
after surgery were kept on the same diet as before the surgery,
and another seven from the group had a changed diet (Fig. 1a).
Number of rats was kept as small as possible in consideration
of the B3Rs^ for the humane treatment of animals [21]. DJOS
and SHAM surgeries were performed when the rats’ average
body weight was 480 ± 50 g. The numbers of rats that sur-
vived in the experimental groups was seven; in the HF/
SHAM/CD group, the number of rats that survived was only
six. Anesthesia was administered according to previously de-
scribed methodology for applying analgesia and antibiotic
prophylaxis [15, 20]. A DJOS was performed according to
Karcz et al. methodology [2] (Fig. 1b, c). Before performing
the duodenoenterostomy, the length of the small bowel was
measured to account for inter-individual differences
(86.1 ± 6.47 cm). Briefly, the gastric volume was left intact,
whereas the entire duodenum and the proximal jejunum were
bypassed. The stomach was separated from the duodenum at
the point just below the pylorus. The distal part of the
transected duodenum was closed using Prolene 6/0
(Ethicon). The position of the duodenoenterostomy was deter-
mined to be at the aboral of the Treitz ligament, located ap-
proximately at one third of the total small bowel length for
DJOS. The duodenojejunostomy was performed as a simple
antecolic, continuous end-to-side hand-sewn extramucosal
anastomosis using 6–0 sutures [2]. For the SHAM operation,
transections and re-anastomosis of the gastrointestinal tract
were performed at the corresponding sites where enterotomies
were performed for the duodenojejunostomy, thereby main-
taining the physiological conduit of food passage through the
bowel. Weight, food intake, fasting, and non-fasting blood
glucose were tracked for 8 weeks after surgery for all groups.
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OGTT, Blood, and Tissue Collection
A total of ten OGTTs were performed to assess glucose me-
tabolism and were performed at 8 weeks before surgery and
8 weeks after surgery. For OGTTs, anesthesia was induced
and maintained using isoflurane 2% and oxygen flow at 2 L/
min breathing rate. The OGTT was initiated after the place-
ment of an orogastric tube (central venous catheter, Arrow
International Inc., Reading, Penn) infusing a 40% glucose
solution at a dosage of 1.5 g/kg. The amount of glucose was
determined via tail snip at 0, 10, 30, 60, 90, and 120 min using
a Glucometer (Ascensia Elite, Bayer Corp, Monheim,
Germany). The first and last OGTTs included blood collection
from the right tail vein for hormone analysis. The right tail
vein was cannulated using a 26-gauge cannula. Blood was
drawn at 0 and 30min after oral glucose was given using tubes
containing 10 μl EDTA (Sigma-Aldrich, St. Louis, USA) and
4 μl DPP-4 inhibitor (DRG Instruments GmbH, Marburg,
Germany). At 8 weeks after surgery, blood for additional hor-
mone analysis was collected from the abdominal aorta via
tubes containing 10 μl EDTA (Sigma-Aldrich, St. Louis,
MO, USA). After centrifugation at 4000 rpm for 10 min at
4 °C, plasma samples were collected and snap frozen in liquid
nitrogen and stored at −80 °C until analysis. After blood sam-
pling, tissues were harvested and the animals were euthanized.
White adipose was explanted and snap frozen in liquid nitro-
gen and stored at −80 °C until further analysis. All
experimental procedures were approved by the Ethical
Committee for Animal Experimentation of the Medical
University of Silesia (58/2014). All applicable institutional
and/or national guidelines for the care and use of animals were
followed (directive 2010/63/EU).
Hormonal Assessment
For hormonal evaluation, blood samples were collected from
the right tail vein, which was dissected and cannulated using a
26-gauge cannula. Blood was drawn via the cannula at 0 and
30 min after oral glucose was given, using tubes containing
10 μl EDTA (Sigma-Aldrich, St. Louis, USA) and 4 μl DPP-4
inhibitor (DRG Instruments GmbH, Marburg, Germany).
After centrifugation at 4000 rpm for 10 min at 4 °C, samples
were snap frozen in liquid nitrogen and stored at −80 °C until
analysis. Insulin, GLP-1 (7-36) and glucose-dependent
insulinotropic peptide, GIP serum concentrations were
assessed in duplicates by sandwich ELISA kits (Cloud-
Clone Corp., USA).
HOMA-IR
A homeostatic model assessment of insulin resistance
(HOMA-IR) was calculated according toMatthews et al. [22].
Fig. 1 a Schematic illustration of
DJOS and b SHAM surgery,
respectively. c Scheme of
experimental groups
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Liver Histology
Transmission Electron Microscopy Analysis
Immediately after collection, samples of liver were fixed in
2.5% glutaraldehyde (SERVA Electrophoresis GmbH-
Heidelberg, Germany) in cacodylate buffer (pH 7.4) for 2 h
at room temperature and then washed several times in the
same buffer. Subsequently, the tissue was post-fixed in 1%
osmium tetroxide (Polysciences Inc., Niles, Illinois, USA),
dehydrated in a graded series of ethanol (50, 70, 90, and
96%) and propylene oxide. The samples were then infiltrated
in 2:1 (vol:vol) and 1:2 (vol:vol) propylene oxide/Epon 812
mixtures, embedded in Epon 812 epoxy resin (SERVA
Electrophoresis GmbH-Heidelberg, Germany), then polymer-
ized for 48 h at 60 °C. Ultrathin sections were cut from rep-
resentative samples with a diamond knife (45; RMC, Tucson,
USA) using a Reichert OmU-3 ultramicrotome (Reichert,
Vienna, Austria), mounted on 300-mesh copper grids and
stained with 0.5% aqueous uranyl acetate and lead citrate
(LAURYLAB Saint-Fons, France) using a Leica EM AC 20
stainer (Leica Microsystems, Vienna, Austria). After air dry-
ing of the grids, they were examined in a TECNAI™ G2 12
Spirit BioTWIN transmission electron microscope (FEI,
Eindhoven, The Netherlands) at 120 kV. Images from repre-
sentative regions were captured with a Morada CCD camera
(Olympus Soft Imaging System Solutions GMBH, Münster,
Germany).
Statistical Analysis
Statistical analysis was performed using STATISTICA 12 PL
(StatSoft, Inc. (2014). STATISTICA (data analysis software
system), version 12. www.statsoft.com), StataSE 12.0
(StataCorp LP, TX, USA). Statistical significance was set at
a p < 0.05. All tests were two-tailed. Interval data were
expressed as mean value ± standard deviation in the case of
normal distribution or as median/inter-quartile range in the
case of data with skewed or non-normal distribution. The dis-
tribution of variables was evaluated by the Shapiro-Wilk test,
and the homogeneity of variances was assessed by the Levene
test. For comparison of data, the two-way ANOVA for inter-
group comparisons and repeated measurement analysis were
used with post hoc contrast analysis.
Results
OGGT Time Profiles
No changes between the two operation types were observed
for groups HF/HF (p = 0.499), HF/CD (p = 0.073), and CD/
HF (p = 0.252). A statistically significant difference in time
profile course in the group CD/CDwas observed (p < 0.01). In
SHAM-type operations, no statistically significant differences
in time profile course were observed. Nevertheless, there was
no common glucose pick in the profile of OGTT for the HF/
HF group in comparison with other groups. In the DJOS-type
operation, differences were observed between groups HF/HF
and CD/CD (p < 0.05), HF/CD and CD/CD (p < 0.001), and
CD/CD and CD/HF (p < 0.01). The highest glucose tolerance
was observed for the CD/CD and HF/HF groups, while a
change of diet (HF/CD, or CD/HF) resulted in disabled glu-
cose tolerance (Fig. 2a).
AUCOGTT
No statistically significant changes between the two operation
types were observed for the groups HF/HF (p = 0.205) and
CD/HF (p = 0.207). In the HF/CD group, AUCOGTT was
statistically significantly higher for DJOS-type surgery than
in the SHAM type (p < 0.05), while in the CD/CD group,
the opposite was found, i.e., the AUCOGTT was higher in the
SHAM group compared with the DJOS group (p < 0.05). For
the DJOS operation groups, the following statistically signif-
icant differences were noted: group CD/CD has lower values
of AUCOGTT than the HF/HF (p < 0.05), HF/CD (p < 0.001),
and CD/HF groups (p < 0.01; Fig. 2b). In contrast, there were
no significant changes in the observed values of HOMA-IR
between DJOS and SHAM groups (Fig. 2c; Table 1).
Insulin
Statistically significant changes between DJOS and SHAM
surgeries were observed for the HF/HF (p < 0.05) and the
CD/HF groups (p < 0.05, Table 1). For both DJOS and
SHAM surgeries, statistically significant differences between
HF/HF and other groups were observed (1 vs. 2, 1 vs. 3, 1 vs.
4; p < 0.001, Fig. 2d).
GLP-1 andΔGLP-1
Statistically significant changes between SHAM and DJOS
surgeries were observed for all analyzed groups: HF/HF
(p < 0.001), HF/CD (p < 0.05), CD/HF (p < 0.01), and CD/
CD (p = 0.001). In the HF/HF group,ΔGLP-1 was statistical-
ly significantly lower for DJOS surgery in comparison with
other groups (1 vs. 2, 1 vs. 3, 1 vs. 4; p < 0.05, p < 0.05,
p < 0.01). For the same type of surgery, the CD/HF group
was statistically significantly lower in comparison with the
CD/CD group (p < 0.05). In the SHAM surgery group, statis-
tically significant differences between HF/HF and the follow-
ing groups were observed (1 vs. 2, 1 vs. 3, 1 vs. 4, p < 0.001;
Fig. 3a, b).
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ΔGIP
Only the CD/HF group (p < 0.05) showed statistically signif-
icant changes of ΔGIP after SHAM and DJOS surgeries, re-
spectively. After DJOS surgery,ΔGIP was statistically signif-
icantly lower in the CD/HF group compared with the HF/HF
group (p < 0.05). After SHAM surgery, the ΔGIP value was
statistically significantly lower for the CD/CD group com-
pared with the other groups (1 vs. 4, 2 vs. 4, 3 vs. 4,
p < 0.001, p < 0.01, p < 0.01) and between the HF/HF and
CD/HF groups (p < 0.05; Fig. 3c).
It can be concluded that statistically significant changes
of almost all analyzed parameters were observed in the CD/
HF groups following either DJOS or SHAM surgery
(Table 2). It suggests that a change of diet, irrespective of
surgery, crucially affects all these parameters. The type of
surgery was, however, shown to be of fundamental impor-
tance for the GLP-1 serum concentration (Fig. 3a, b). The
effect of HF on selected parameters like insulin and GLP-1
was clearly visible when comparing DJOS and SHAM
surgeries.
Weight
After surgery, bodyweight development was largely similar in
the DJOS and SHAM groups (Fig. 3d). Statistically signifi-
cant differences of weight changes were observed for groups
HF/HF and HF/CD (p < 0.001) at each time of measurement.
The overall food intake pattern was similar in the analyzed
groups of DJOS and SHAM animals (Fig. 3e). There was a
significant change in food intake between the CD/HF group
and other the studied groups for DJOS and SHAM. A change
of diet to a more caloric one after DJOS surgery did not lead to
significant weight loss when the surgery was not combined
with gastric restriction. In our experiment, we could observe
that a HF reduced the effects of the surgery, in contrast with
other reported types of surgery [23].
Results of Liver Histology
Histology analysis of liver tissues from the HF/HF groups
subjected to DJOS and SHAMwere analyzed by transmission
Fig. 2 a Glucose profiles of OGGT in four groups of diet, according to
the operation type. Ninety-five percent confidence interval (95% CI) as
calculated from Student’s t test. b AUC of glucose profiles of OGGT in
four groups of diet, according to the operation type. 95% CI as calculated
from Student’s t test. cMean values of HOMA-IR in four groups of diet,
according to the operation type. 95% CI as calculated from Student’s t
test. dMean values of delta insulin in four groups of diet, according to the
operation type. 95% CI as calculated from Student’s t test
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electron microscopy (Figs. 4a–d and 5a–f). In order to indirect
quantification of fat content, obtained images were analyzed
statistically. From each photograph, total surface of the all-fat
droplets were calculated with respect to whole visible tissue
area. Electron microscopy studies revealed the presence of
single small lipid droplets in hepatocytes (Fig. 4a–d). Thus,
it can be inferred (1.11 ± 0.52%, Fig. 5f) that no fat accumu-
lation was observed 8 weeks after DJOS surgery in the liver of
animals which were kept on a HF diet (Fig. 4a–d). In contrast,
fat accumulation visible as numerous lipid droplets of variable
sizes in the hepatocytes cytoplasm (17.56 ± 6.94%; Fig. 5f)
was observed after SHAM surgery. Furthermore, the hepatic
tissues revealed normal ultrastructure in animals of both
groups.
Discussion
It is estimated that up to 90% of people with T2D suffer from
obesity, and 80% of subjects with T2D are diagnosed with
metabolic syndrome [24]. But it has also been shown that
body weight and type 2 diabetes are not in direct causal rela-
tionship because 10% of diabetic patients are thin and around
75% of obese patients are not diabetic [10]. Meta-analysis of
weight and bariatric surgery shows that the most efficient bar-
iatric procedures, in terms of weight loss, are the
biliopancreatic diversion/duodenal switch groups followed
by gastric bypass, gastroplasty, laparoscopic adjustable gastric
banding, and that the relative effectiveness of these treatments
is similar up to about 2 years after the intervention [10]. The
treatment of obesity and type 2 diabetes with metabolic sur-
gery influences the physiological role of incretins like GLP-1,
GIP, and PYY, which are important players in glucose homeo-
stasis improvement [25]. DJB surgery has also been reported
to result in increased GLP-1 secretion [25–28] and is also
associated with the improvement of sensitivity to insulin [29].
Insulin Intolerance and Incretins
Here, it is reported for the first time that a proper diet applied
before and after DJOS surgery is crucial for body weight,
glucose tolerance, and insulin resistance but not for GLP-1
and hepatic concentration of fat, which depends on the type
of surgery one undergoes. GLP-1 plasma concentration, mea-
sured before and after surgery, was significantly different for
DJOS and SHAM groups despite whichever of the diets was
applied. Interestingly, after the surgery, the GLP-1 concentra-
tion was significantly higher in the group maintained on a HF
when compared with other dietary groups and SHAM ani-
mals. It was also associated with higher glucose tolerance
and the lowest plasma glucose levels in the group maintained
on a HF. In rats, a HF has a negative impact on GLP1-r ex-
pression, which is reduced after 3 months of feeding rats,Ta
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leading to nonalcoholic steatohepatitis (NASH) and nonalco-
holic fatty liver disease (NAFLD) [30]. The presence of GLP-
1 receptors on rats’ hepatocytes, as well as increased GLP-1
levels after surgery, has a direct effect on hepatocytes by acti-
vating the genes involved in fatty acidβ-oxidation and insulin
sensitivity [30]. In our previous study, we showed that long
segment ileal transposition surgery shows a rapid rise in GLP-
1 and PYY levels, thus leading to early amelioration of glu-
cose control. In this study, we can conclude that GLP-1 me-
diates the metabolic benefits of DJOS in a weight loss-
independent and diet-independent manner. Reversely, GIP
plasma levels, before and after surgery, were lowered in
DJOS groups when compared with the SHAM groups, except
for those groupsmaintained only on a CD (before and after the
surgery). GIP is a gastrointestinal hormone released in re-
sponse to nutrient ingestion and potentiate glucose-
stimulated insulin secretion. GIP is known to increase the
volume of adipose tissue by binding to the GIP receptor lo-
cated on the adipocytes and by accelerating fat deposition and
expansion of fat depots by increasing insulin secretion from
pancreatic β-cells [31, 32]. GIP has a physiological role for
nutrient uptake into adipocytes and is a key molecule linking
over-nutrition to obesity. Excessive fat intake in rats induces
GIP gene expression and hypersecretion of GIP. This in-
creases nutrient uptake in the adipocytes leading to obesity
and insulin resistance. Reversely, inhibition of the GIP signal
in GIP receptor knockout (KO) mice prevents insulin resis-
tance as well as obesity [33]. Yamada has shown that in the
situation of GIP receptor aberration, fat is not properly accu-
mulated in adipocytes and is used as the preferred energy
source [33]. Our study also shows that exclusion of duodenum
and the proximal part of jejunum leads to a decrease of GIP
levels after surgery but with an unexpected exception for the
group maintained on a HF only. Over-nutrition with fat is a
very strong factor, which dramatically reduces the effects of
DJOS surgery. Nevertheless, comparing the changes inΔGIP
levels, the effect of DJOS was visible in animals maintained
on a HF or mixed CD/HF and HF/CD diets, with the strongest
effect occurring in the CD/HF group. The change of the diet
from a CD to a HF had the strongest impact on GIP levels,
which were significantly increased in the SHAM animals
when compared with animals that underwent the DJOS sur-
gery. Many studies show positive results of bariatric surgery
on the resolution of DM2T and obesity [25, 26, 34]. In sum-
mary, we have shown that GLP-1 levels increase following
DJOS irrespective of body weight changes. Transition to
Fig. 3 aMean values of
glucagon-like peptide 1 in four
groups of diet, according to the
operation type. 95% CI as
calculated from Student’s t test. b
Mean values of delta glucagon-
like peptide 1 in four groups of
diet, according to the operation
type. 95% CI as calculated from
Student’s t test. cMean values of
delta gastric inhibitory
polypeptide in four groups of diet,
according to the operation type.
95% CI as calculated from
Student’s t test. dWeight profiles
in four groups of diet, according
to the operation type. 95% CI as
calculated from Student’s t test. e
Mean values of Eq in four groups
of diet, according to the operation
type. 95% CI as calculated from
Student’s t test
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another diet after surgery impaired insulin tolerance and GIP
effect more than keeping the animals on the same type of diet.
After OGTT, animals in DJOS showed improved glucose tol-
erance for HF/HF and CD/CD in relation to the SHAM ani-
mals. DJOS rats showed significantly reduced AUCOGTT for
the HF/HF and CD/CD groups.
Diet Effect
Previous experimental model studies have shown a recurrence
of glucose intolerance after an initial improvement directly
after surgery [35]. Our results show that different types of
diets, applied before and after surgery, may be considered a
valuable and close to human behavior model for the investi-
gation of the mechanism of glucose intolerance after bariatric
surgery. In this study, we decided to use a HF in order to
induce obesity and insulin resistance. A HF is considered a
factor which decreases insulin ability for suppression of he-
patic glucose production and lowers glucose uptake [36].
After 8 weeks on a HF, we observed an impaired insulin tol-
erance in all animals selected for DJOS surgery. After DJOS
surgery, the glucose tolerance was ameliorated in both the HF/
HF and CD/CD groups but not in the groups of animals whose
diet was changed from a HF to a CD and from a CD to a HF.
The glucose amelioration in HF/HF subjects was found to be
comparable with the control group, which can be an effect of
ketogenic properties of a HF. This contrasts with other find-
ings, which showed that a high-caloric diet was an important
reason for the retreat of improvement in diabetes after surgery
[35]. The amount of food and quality of food was not reduced
and changed before and after surgery. We appreciate that for
some of the studied parameters, HF diet had stronger impact
than surgery itself. This effect would probably be much more
accentuated if connected to gastric restriction. We should
stress here that time after surgery is also an important or even
crucial influential factor, so to compare our results with the
others, the similar protocols are necessary, meanwhile the
available results present the full spectrum of surgeries, diets,
and periods.
Impact of DJOS on Body Weight
In this study, DJOS surgery was shown to have very little
impact on body weight reduction. In all groups, the bodymass
was increased after DJOS surgery. In the DJOS groups, the
body weight had no negative effect on insulin levels, glucose
tolerance, or liver fat deposition. We can conclude that after
DJOS, even though the body weight increased, the ameliora-
tion of glucose tolerance was reached for the HF/HF and CD/
CD groups but not for the mixed diet groups (HF/CD and CD/
HF). Changes in diet after surgery influenced the glucose-
stimulated insulin secretion. HF diet, less carbohydrates, and
a more obesogenic diet applied before and after the surgeryTa
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decreased levels of plasma insulin when compared with other
groups. It was combined with a continuous decrease in plasma
glucose level in the HF/HF group but not in the CD/HF group,
which might be associated with a high level of GLP-1 [27,
29]. Liu and coworkers observed that this trend may change
with time. After long-term observation, 16 weeks after DJB
surgery, the increased caloric intake reduced the beneficial
effects of the surgery and resulted in decreased insulin sensi-
tivity, thus leading to re-impairment of glucose tolerance and
reversal of the initial improvement [35]. Our results show that
DJOS surgery did not reduce body weight in groups main-
tained on a HF, but instead prevented lipid accumulation in the
liver. Similar results were obtained for the remediation of
NAFLD and NASH after Roux-en-Y gastric bypass
(RYGB) and sleeve gastrectomy surgeries [37]. We note that
the gastric size was not reduced after DJOS. According to
current literature, we may however conjecture that gastric re-
duction will influence body mass and amount of food con-
sumed by studied animals. That was the main reason why
we decided to study DJOS and ketogenic diet without any
supplementary surgery. In that aspect, we are here able to
study effects of DJOS on selected parameters not influenced
by changed, limited amount of food consumed, or other ef-
fects of gastric reductions.
Conclusions
In this study, the effect of DJOS surgery was analyzed after
8 weeks with respect to body weight, glucose tolerance, and
incretins in Sprague-Dawley obese rats maintained on an
obesogenic diet, which is known to produce metabolic dys-
function in the liver and on a regular controlled diet. The main
findings are (i) in short-termDJOS surgery, it was found not to
reduce body weight in the studied groups, except the control
group CD/CD where a slight reduction was observed, (ii)
selected incretin GLP-1 levels increased following DJOS
Fig. 4 a–d Electron micrographs
of rat liver (HJ/DJOS/HF group)
showing hepatocytes with
euchromatic nucleus (N) of
regular outline and prominent
nucleolus. The cytoplasm
contains round and oval
mitochondria (M), multiple arrays
of rough endoplasmic reticulum
(rER), glycogen (G), multiple
peroxisomes (P), and a few lipid
droplets of different sizes
(arrowheads) are noticed in
cytoplasm
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irrespective of body weight change, (iii) DJOS surgery pre-
vents lipid accumulation in the liver for the HF/HF groups,
(iv) change of diet after surgery impaired insulin tolerance and
GIP effect more than keeping the animals on the same type of
diet before and after surgery, and (v) based on OGTT, animals
which underwent DJOS surgery showed improved glucose
tolerance for HF/HF and CD/CD. For those groups, the 30-
and 60-min plasma glucose levels were consistently lower in
relation to SHAM animals, (vi) DJOS animals exhibited sig-
nificantly reduced AUCOGTT for the HF/HF and CD/CD
Fig. 5 a–f Electron micrographs
of rat liver, HF/SHAM/HF group.
a–eMultiple and different size
lipid droplets (arrowheads)
occupy most of the cytoplasm.
Moreover, the cytoplasm contains
mitochondria (M), rough
endoplasmic reticulum (rER), and
single lysosomes (L). a Two
adjacent hepatocytes enclosing a
bile canaliculus, note little amount
of condensed heterochromatin
within the nucleus (N). c, d The
blood sinusoids (S) between
hepatocytes are visible. f
Statistical analysis between HJ/
DJOS/HF group (light bar) vs.
HF/SHAM/HF group (dark bar).
Asterisk indicates statistical
difference at p < 0.05
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groups, and therefore ameliorated glucose tolerance, and (vii)
DJOS surgery together with HF influenced the level of insulin
in all subjects.
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